• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.31% Nasdaq Up 0.98%

    Janus Global Life Sciences C (JFNCX)

    52.46 Up 0.55(1.06%) Jan 29
    Prev Close:51.91
    YTD Return*:33.65%
    Net Assets*:3.28B
    Yield*:N/A

    * As of 31-Dec-14

    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    • No Headlines available for JFNCX at this time.

    Top Holdings

    Symbol% AssetsYTD Return %
    GILD3.360.69
    VRX.TO2.680.94
    CELG2.571.48
    MNK2.56-2.09
    JNJ2.52-0.05

    Fund Basics

    Morningstar Overall Rating:
    Total Assets:3.28B
    Category:Health
    Annual Report Expense Ratio (net):1.80%

    Performance & Risk

    YTD Return:33.65%
    5y Avg Return:23.80%
    Rank in Category (ytd):17
    % Rank in Category (ytd):13.49%
    Beta (3y):0.68
    Morningstar Risk Rating:3

    Fund Summary

    The investment seeks long-term growth of capital. The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets in securities of companies that the portfolio manager believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback